Article: Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
2024 Volume 29, Issue 3, Page(s) 101490
Abstract: Introduction and objectives: Intrahepatic cholestasis of pregnancy (ICP) is often accompanied by fetal and maternal complications.: Materials and methods: Retrospective review of the clinical course of women with ICP and their neonates treated at our ...
Abstract | Introduction and objectives: Intrahepatic cholestasis of pregnancy (ICP) is often accompanied by fetal and maternal complications. Materials and methods: Retrospective review of the clinical course of women with ICP and their neonates treated at our medical center over a 10-year period. Special attention was paid to the maternal and neonatal response to 2 different modes of ursodeoxycholic acid (UDCA) administration. Results: Neonates of mothers with high total bile acid levels had a poorer composite neonatal outcome. Twenty-seven women who presented at an advanced stage of their pregnancies did not receive UDCA. UDCA was administered in 2 modes: either a full dose at admission (76 women) or a gradually increasing dose until the desired dosage was reached (25 women). The mean gestational age at delivery for the 94 neonates that were exposed to full UDCA dose was the lowest (36±2.3 weeks for the full dose, 37±1.4 weeks for the 30 neonates from the gradually increasing dose, 38±1.6 weeks for the 29 neonates from the no treatment group, p<0.001). The group of neonates that were exposed to full UDCA dose had the highest rate of unfavorable composite neonatal outcome (53% for full dose, 30% for gradually increasing dose, 24% for the no treatment group, p=0.006). Conclusions: Compared to the administration of a full UDCA dose, the administration of a gradually increasing dose of UDCA may be associated with a greater gestational age at delivery and fewer events of unfavorable composite neonatal outcomes. These novel findings should be retested prospectively in a large cohort of patients. |
---|---|
MeSH term(s) | Humans ; Ursodeoxycholic Acid/administration & dosage ; Ursodeoxycholic Acid/therapeutic use ; Female ; Pregnancy ; Cholestasis, Intrahepatic/drug therapy ; Cholestasis, Intrahepatic/diagnosis ; Cholestasis, Intrahepatic/blood ; Retrospective Studies ; Pregnancy Complications/drug therapy ; Pregnancy Complications/blood ; Infant, Newborn ; Cholagogues and Choleretics/administration & dosage ; Cholagogues and Choleretics/adverse effects ; Cholagogues and Choleretics/therapeutic use ; Adult ; Gestational Age ; Treatment Outcome ; Pregnancy Outcome |
Chemical Substances | Ursodeoxycholic Acid (724L30Y2QR) ; Cholagogues and Choleretics |
Language | English |
Publishing date | 2024-02-23 |
Publishing country | Mexico |
Document type | Journal Article |
ZDB-ID | 2188733-0 |
ISSN | 1665-2681 |
ISSN | 1665-2681 |
DOI | 10.1016/j.aohep.2024.101490 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6221: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.